RxSight (NasdaqGM:RXST) is riding high on a 12.18% surge in its price target to 50.49 per share. Analysts revised the target upwards, steered by a robust increase from the prior estimate of 45.01 as of January 16, 2024. This surge reflects a bullish stance on the stock’s potential.
The Pulse of Fund Sentiment
At present, 331 funds or institutions have holdings in RxSight. This marks an uptick of 57 owners or 20.80% in the last quarter alone. The overall average portfolio weight allocated to RXST stands at 0.15%, signaling a slight dip of 6.66%. Institutions have raised their stakes by 14.59% to 34,049K shares over the past three months. The put/call ratio of RXST is currently at 0.18, reflecting a bullish sentiment.
Insights into Shareholder Behavior
Ra Capital Management has significantly boosted its holding in RxSight by upping its shares to 3,404K, capturing a 9.49% ownership stake. The firm’s portfolio allocation increased by a notable 26.96% in the last quarter, showcasing a bullish outlook on the stock.
On the flip side, Artisan Partners Limited Partnership trimmed its holdings to 2,396K shares, representing a 6.68% ownership share. Despite the reduction in shares compared to its previous filing, the firm decisively increased its portfolio allocation in RXST by 28.91% during the last quarter.
Meanwhile, Lord, Abbett & Co. seized a 5.51% ownership slice by holding 1,977K shares. Notably, the investment firm escalated its interest in RXST by a hefty 66.31% in the last quarter, emphasizing its confidence in the stock’s potential growth.
ARTJX – Artisan International Small-Mid Fund Investor Shares reinforced its position by hiking its holdings to 1,490K shares, amounting to a 4.15% ownership share. The firm raised its portfolio allocation in RXST by 19.88% in the past quarter, painting a positive picture of the stock’s prospects.
T. Rowe Price Investment Management surged its ownership to 958K shares, translating to a 2.67% stake in the company. The firm significantly boosted its holdings by 43.57% from the previous filing, showcasing a remarkable increase in confidence in RXST.
Fintel stands as a premier investing research platform catering to a diverse audience of individual investors, traders, financial advisors, and small hedge funds. Our robust data offering spans the globe, delivering fundamental insights, analyst reports, ownership data, and sentiment across various financial instruments.
Dive deeper into our comprehensive suite of tools, including options sentiment, insider trading analysis, and exclusive stock picks propelled by advanced quantitative models to enhance trading outcomes.
Unravel the full story on Fintel and elevate your investing acumen.
Kindly note that the views expressed herein solely represent the author’s perspective and may not align with those of Nasdaq, Inc.
